Methods: It was a randomized, parallel, open label, study among pregnant women of
gestational age between 12 to 26 wk with moderate anaemia. Patients were randomly …

Iron deficiency anaemia is a major public health problem in pregnancy. About 58% of
pregnant women in developed countries are anaemic mainly due to iron deficiency resulting …

Background The efficacy of iron polymaltose complex (IPC) in the treatment of iron
deficiency anemia (IDA) during pregnancy has not been well established, and the evidence …

Objectives: This study was designed to compare efficacy and conduct cost effective analysis
of three commonly used oral iron preparations among anemic women (n= 150) of gestation …

Objective: To evaluate the efficacy and safety of iron (III) polymaltose complex (Maltofer®)
versus ferrous sulfate in iron-deficient pregnant women using recommended doses …

Anaemia is the most common medical disorder in pregnancy with iron deficiency anaemia
accounting for the majority of cases. Over 90% of the iron deficiency anaemia is due to red …

Aim: Iron deficiency anemia is the most common nutritional disorder in pregnancy and
approximately 40% of all pregnant women are complicated with perinatal morbidity and …

Iron deficiency anemia in women of reproductive age group is a major health problem in
Egypt. Objective: The present study was designed to compare the efficacy and tolerability of …

Ironhydroxide polymaltose (IPC) preparations were used to treat four pregnant women with
iron deficiency anemia. Despite patient compliance for sufficient length of time, hemoglobin …

Objective To compare the therapeutic efficacy of Ferrous ascorbate (FA) and Iron
polymaltose complex (IPC) in Iron deficiency anemia (IDA) in children. Methods A …